COLLINS & AIKMAN CORPORATION – Trademark Portfolio
Entity Type: 03
COLLINS & AIKMAN CORPORATION has 169 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include GUARDIAN and POWERBOND. The portfolio includes 2 registered trademarks. Filings span 11 Nice Classification classes, led by Class 24 (Fabrics) and Class 25 (Clothing).
Showing of trademarks Trademarks
Trademark Classifications
COLLINS & AIKMAN CORPORATION's trademark portfolio spans 11 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does COLLINS & AIKMAN CORPORATION have?
COLLINS & AIKMAN CORPORATION has 169 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 abandoned, 159 cancelled.
What trademark classes does COLLINS & AIKMAN CORPORATION file in?
COLLINS & AIKMAN CORPORATION files trademarks across 11 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 25 (Clothing), Class 27 (Floor Coverings), Class 23 (Yarns & Threads), Class 40 (Treatment & Processing). Class 24 covers textiles and textile goods; bed covers; table covers.
What are COLLINS & AIKMAN CORPORATION's most well-known trademarks?
COLLINS & AIKMAN CORPORATION's registered trademark portfolio includes well-known marks such as GUARDIAN and POWERBOND. These are among 2 currently registered trademarks in the portfolio.
What is COLLINS & AIKMAN CORPORATION's trademark registration success rate?
COLLINS & AIKMAN CORPORATION has a 1% trademark registration rate, with 2 out of 169 resolved applications resulting in successful registration. Currently, 0 applications are pending review.